Companies

Learn how companies pay their employees. Browse by industry and income levels.

Browse Companies by Letter

Navidea Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of precision immunodiagnostic agents and immunotherapeutics. The company operates in two segments, Diagnostic Substances and Therapeutic Development Programs. The company develops Manocept platform to target the CD206 mannose receptor expressed on activated macrophages. Its CD206-targeted drug platform is applicable to a range of diagno... View company details



Navmar Applied Sciences Corporation is a SDVOSB (NAICS Code 336411, Aircraft Manufacturing) company specializing in avionics-related technologies and ranging from design and development through test and evaluation to end-product and parts manufacturing. Navmar is also widely recognized in the avionics-related core competencies of sensors, air-vehicle technologies, advanced material development, and flight simulation. View company details


The Small Business and Technology Development Center (SBTDC) is North Carolina's leading resource for growing and developing businesses. Since 1984, the SBTDC has helped over 125,000 North Carolina business owners and prospective entrepreneurs make better decisions - often leading to increased revenue and employment. We are administered by N.C. State University on behalf of The University of North Carolina System and operated in partnership with ... View company details




Creating a future where aircraft fly safely and autonomously. View company details



NEEDLE SPECIALTY PRODUCTS is a medical devices company based out of 600 HWY 446, BOYLE, Mississippi, United States. View company details


Nektar Therapeutics develops drug candidates for cancer, auto-immune disease, and chronic pain in the United States. The company develops NKTR-181, an orally-available mu-opioid analgesic molecule, which is in Phase III clinical trial for moderate to severe chronic pain; ONZEALD, a topoisomerase I inhibitor that is in Phase III clinical trial for advanced metastatic breast cancer in patients with brain metastases; and NKTR-214, a CD122-preferenti... View company details